BVF PARTNERS L P/IL
Transactions
50
Companies
27
Filings
1
CIK
0001055947
Recent Transactions
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Disposition to Issuer
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,418,736→ 2,165,776 total - Award
- Award
- Award
- Disposition to Issuer
Common stock, $0.0001 par value
2024-12-04−1,797,527→ 2,891,427 total - Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Award
Companies
27- $FDMT
4D Molecular Therapeutics, Inc.
10% Owner
AMAG PHARMACEUTICALS, INC.
10% Owner, Indirect Beneficial Owner
ARENA PHARMACEUTICALS INC
10% Owner, Indirect Beneficial Owner
ARQULE INC
10% Owner, Indirect Beneficial Owner
ARRAY BIOPHARMA INC
10% Owner, Indirect Beneficial Owner
AVIGEN INC \DE
10% Owner, Indirect Beneficial Owner
- $BCRX
BIOCRYST PHARMACEUTICALS INC
10% Owner, Indirect Beneficial Owner
- $CAPS
Capstone Holding Corp.
10% Owner
CORVAS INTERNATIONAL INC
10% Owner
CytoCore, Inc.
10% Owner, Indirect Beneficial Owner
- $CYTK
CYTOKINETICS INC
10% Owner
- $DVAX
DYNAVAX TECHNOLOGIES CORP
10% Owner
EPIRUS Biopharmaceuticals, Inc.
10% Owner, Indirect Beneficial Owner
GENAERA CORP
10% Owner
INFINITY PHARMACEUTICALS, INC.
10% Owner
- $KYMR
Kymera Therapeutics, Inc.
Director, See Remarks and Footnotes
- $LGND
LIGAND PHARMACEUTICALS INC
10% Owner, Indirect Beneficial Owner
- $MRUS
Merus N.V.
10% Owner
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
10% Owner, Indirect Beneficial Owner
- $NBIX
NEUROCRINE BIOSCIENCES INC
10% Owner, Indirect Beneficial Owner
NEUROGEN CORP
10% Owner, Indirect Beneficial Owner
- $OLMA
Olema Pharmaceuticals, Inc.
Director, See Explanation of Responses
- $RPTX
Repare Therapeutics Inc.
10% Owner
REPROS THERAPEUTICS INC.
10% Owner, Indirect Beneficial Owner
SGX PHARMACEUTICALS, INC.
10% Owner, Indirect Beneficial Owner
- $GPCR
Structure Therapeutics Inc.
10% Owner
Tobira Therapeutics, Inc.
10% Owner
Recent Filings
1Address
44 MONTGOMERY STREET 40TH FL
SAN FRANCISCO, CA, 94104